Literature DB >> 11009081

Differential regulation of Ly49 expression on CD4+ and CD4-CD8- (double negative) NK1.1+ T cells.

M Sköld1, S Cardell.   

Abstract

The pan-NK cell marker NK1.1, present in some mouse strains, is also found on a subset of TCRalphabeta+ lymphocytes termed NKT cells. These cells are primarily CD4+ or CD4-CD8- (double negative, DN), and both NKT subpopulations contain cells reactive with the MHC class I-like molecule CD1d. Murine NK cells express clonally distributed inhibitory receptors of the Ly49 family that bind to different alleles of MHC class I molecules and transmit negative signals regulating NK cell function. Ly49 receptors are also found on TCRalphabeta+ NK1.1+ T cells. To investigate the potential role of inhibitory Ly49 markers in the regulation of NKT cells, we have done a thorough analysis of their expression on different NKT populations. The CD4+ and DN NK1.1+ T cell subsets have traditionally been dealt with as one NK1.1+ T cell population, but we found dramatic differences between these two NKT cell subsets. We demonstrate here expression of Ly49 receptors on DN, but not on CD4+, NK1.1+ T cells in spleen and liver. Absence of the specific MHC class I ligand in the host was associated with elevated levels of expression and, to a greater extent than has been found for NK cells, increased the frequencies of Ly49-positive cells within the DN subset, while CD4+ NK1.1+ cells remained negative. In the thymus and bone marrow both NK1.1+ T cell subsets contained high frequencies of Ly49-positive cells. Results from in vitro stimulation of DN NKT cells further suggest that activation and expansion of NKT cell subsets are regulated by the Ly49 receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009081     DOI: 10.1002/1521-4141(200009)30:9<2488::AID-IMMU2488>3.0.CO;2-F

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation.

Authors:  Anick Chalifour; Joanne Roger; Suzanne Lemieux; Pascale Duplay
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

2.  MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.

Authors:  Markus Sköld; Martin Stenström; Stephane Sidobre; Petter Höglund; Mitchell Kronenberg; Susanna Cardell
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

Review 3.  Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions.

Authors:  Patrick J Brennan; Manfred Brigl; Michael B Brenner
Journal:  Nat Rev Immunol       Date:  2013-01-21       Impact factor: 53.106

4.  Primary infection of C57BL/6 mice with Plasmodium yoelii induces a heterogeneous response of NKT cells.

Authors:  Valérie Soulard; Jacques Roland; Christèle Sellier; Anne Charlotte Gruner; Maria Leite-de-Moraes; Jean-François Franetich; Laurent Rénia; Pierre-André Cazenave; Sylviane Pied
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

5.  Defining the immune response to Ehrlichia species using murine models.

Authors:  Stephen K Chapes; Roman R Ganta
Journal:  Vet Parasitol       Date:  2008-10-17       Impact factor: 2.738

Review 6.  Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.

Authors:  Tin Kyaw; Karlheinz Peter; Yi Li; Peter Tipping; Ban-Hock Toh; Alex Bobik
Journal:  Br J Pharmacol       Date:  2017-06-13       Impact factor: 8.739

7.  A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance.

Authors:  Masaki Terabe; Jeremy Swann; Elena Ambrosino; Pratima Sinha; Shun Takaku; Yoshihiro Hayakawa; Dale I Godfrey; Suzanne Ostrand-Rosenberg; Mark J Smyth; Jay A Berzofsky
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

8.  Extrinsic allospecific signals of hematopoietic origin dictate iNKT cell lineage-fate decisions during development.

Authors:  Beverly S I Strong; Tess J Newkold; Amanda E Lee; Lucas E Turner; Amir M Alhajjat; Jonathan W Heusel; Aimen F Shaaban
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

9.  Functional Characterization of Ly49+CD8 T-Cells in Both Normal Condition and During Anti-Viral Response.

Authors:  Dmytro Shytikov; Deepak Rohila; Dan Li; Pengfei Wang; Mei Jiang; Mingxu Zhang; Qin Xu; Linrong Lu
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

10.  Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.

Authors:  Y Ikarashi; R Mikami; A Bendelac; M Terme; N Chaput; M Terada; T Tursz; E Angevin; F A Lemonnier; H Wakasugi; L Zitvogel
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.